Position added successfully to:
Please name your holdings portfolio Type: BUY SELL Date: Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission: Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close CRM +0.86% Add to/Remove from Watchlist Add to Watchlist Add Position
Position added successfully to:
Please name your holdings portfolio Type: BUY SELL Date: Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission: Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close ILMN +7.73% Add to/Remove from Watchlist Add to Watchlist Add Position
Position added successfully to:
Please name your holdings portfolio Type: BUY SELL Date: Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission: Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close LHX +0.95% Add to/Remove from Watchlist Add to Watchlist Add Position
Position added successfully to:
Please name your holdings portfolio Type: BUY SELL Date: Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission: Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close
Wells Fargo (NYSE:WFC) downgraded Lockheed Martin (NYSE:LMT) to Equal Weight from Overweight and adjusted its price target to $415.00 from $406.00. According to the analysts, the company’s shares trade at a premium to its defense peers on pension-adjusted EPS, although its portfolio lends itself to lower growth vs peers with F-35 (25-30% of sales) no longer growing, while its share of rotorcraft is likely to fall unless it can win the upcoming Future Vertical Lift contract (expected in October).
Wells Fargo downgraded L3Harris Technologies (NYSE:LHX) to Equal Weight from Overweight and lowered its price target to $238.00 from $272.00, noting that the company’s shares trade at a discount to its defense peers, despite its supply chain challenges expected to linger, making the planned approximately 10% sequential H2 sales uptick difficult.
OTR Global downgraded Illumina (NASDAQ:ILMN) to Mixed from Positive.
Cleveland Research downgraded salesforce.com (CRM) to Neutral from Buy.
By Davit Kirakosyan